- What is the current operational status of Peritech Pharma?
- Peritech Pharma is currently inactive, having ceased operations in December 2023.
- What is Peritech Pharma's primary focus in the pharmaceutical industry?
- Peritech Pharma specializes in developing specialty pharmaceutical products for the anal/rectal area.
- What was Peritech Pharma's employee count prior to becoming inactive?
- Peritech Pharma had 1-10 employees.
- Which countries were targeted by Peritech Pharma's business models?
- Peritech Pharma targeted geographies including China, Russia, and South America.
- What was the primary sector classification for Peritech Pharma?
- Peritech Pharma's primary sector was Health Tech & Life Sciences.
- Did Peritech Pharma secure any commercial agreements for its products?
- Yes, Peritech Pharma secured a commercial agreement with Latam BD Group for its over-the-counter products, PP-110 (for hemorrhoids) and PP-120 (for anal itching). This deal included manufacturing and marketing in Brazil and 23 other countries in Central and South America, as well as the Caribbean.
- What is notable about Peritech Pharma's product PP-110?
- PP-110, based on pramoxine HCl 1% and phenylephrine 0.25%, demonstrated a long-lasting effect in a randomized clinical trial, with once-daily use showing better results for pain, itching, and bleeding compared to comparable drugs used three to four times daily.
- When was Peritech Pharma founded?
- Peritech Pharma was founded in March 2012.
